Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: SPAULDING CLINICAL RESEARCH, LLC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2021-09-10 to 2024-10-10
Current total value of award: $1429138.43
Description: OFFICE OF CLINICAL PHARMACOLOGY - NEW TASK ORDER #4 AGAINST SPAULDING CLINICAL STUDIES IDIQ 75F40119D10032 - CLINICAL ECG STUDIES TO EVALUATE ELECTROPHYSIOLOGICAL EFFECTS OF POTENTIAL QT PROLONGING DRUGS WITH NOVEL ECG BIOMARKERS